Charles Schwab (SCHW) Form 4: Director Adds RSUs via Deferred Plan
Rhea-AI Filing Summary
Form 4 filing for The Charles Schwab Corporation (SCHW) discloses that director Stephen A. Ellis acquired 371 restricted stock units (RSUs) on 07/01/2025 under the company’s Directors’ Deferred Compensation Plan II. The RSUs, received in lieu of cash board fees, are held in a rabbi trust and will be distributed when the director leaves the Board. Following the transaction, Ellis now beneficially owns 11,626.64 RSUs, including 34.77 units accumulated through dividend reinvestment. No shares were sold, and the filing reflects routine equity-based compensation rather than an open-market purchase.
Positive
- Director equity alignment: Additional RSUs modestly increase insider ownership, fostering alignment with shareholder interests.
Negative
- None.
Insights
TL;DR: Routine RSU grant; minimal market impact.
The filing records an automatic RSU award tied to Schwab’s deferred compensation plan. Because the transaction is compensation-related, small in size, and involves no cash outlay or share sale, it carries negligible valuation or liquidity implications. Nonetheless, continued equity accumulation by an independent director marginally aligns board interests with shareholders. Overall, this is a standard administrative disclosure rather than a signal of insider sentiment.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 371 | $0.00 | -- |
Footnotes (1)
- Each restricted stock unit ("RSU") represents a right to receive one share of company stock. The RSUs were received pursuant to the Directors' Deferred Compensation Plan II (the "Plan") and are held in a rabbi trust for the benefit of the reporting person pursuant to the terms of the Plan. The RSUs are held in a rabbi trust for the benefit of the reporting person and are distributed to the reporting person when he leaves the Board of Directors. The RSUs were received in lieu of cash compensation otherwise payable as director fees. Includes 34.77 RSUs acquired through dividend reinvestment.